Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07486115
PHASE1

A Study to Test How Different Doses of BI 3814916 Are Tolerated by Healthy People

Sponsor: Boehringer Ingelheim

View on ClinicalTrials.gov

Summary

The main objectives of this trial are to investigate safety, tolerability and pharmacokinetics (PK) of BI 3814916 in healthy male and female trial participants.

Official title: A Phase 1, Randomised, Single-blind, Placebo-controlled Trial to Assess Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of BI 3814916 in Healthy Male and Female Subjects

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

136

Start Date

2026-05-18

Completion Date

2027-07-12

Last Updated

2026-04-02

Healthy Volunteers

Yes

Conditions

Interventions

BIOLOGICAL

BI 3814916

BI 3814916

DRUG

Placebo matching BI 3814916

Placebo matching BI 3814916

Locations (1)

SGS Life Science Services - Clinical Research

Edegem, Belgium